A proteome-wide systems toxicological approach deciphers the interaction network of chemotherapeutic drugs in the cardiovascular milieu. Issue 36 (4th June 2018)

• Record Type: Journal Article
• Authors: Giri, Suvendu; Manivannan, Jeganathan; Srinivasan, Bhuvaneswari; Sundaresan, Lakshmikirupa; Gajalakshmi, Palanivel; Chatterjee, Suvro
• Is Part Of: RSC advances. Volume 8:Issue 36(2018)
• Page Start: 20211
• Page End: 20221
• Publication Date: 2018-06-04
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c8ra02877j
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : Onco-cardiology is critical for the management of cancer therapeutics since many of the anti-cancer agents are associated with cardiotoxicity. Abstract : Onco-cardiology is critical for the management of cancer therapeutics since many of the anti-cancer agents are associated with cardiotoxicity. Therefore, the major aim of the current study is to employ a novel in silico method combined with experimental validation to explore off-targets and prioritize the enriched molecular pathways related to the specific cardiovascular events other than their intended targets by deriving relationship between drug-target-pathways and cardiovascular complications in order to help onco-cardiologists for the management of strategies to minimize cardiotoxicity. A systems biological understanding of the multi-target effects of a drug requires prior knowledge of proteome-wide binding profiles. In order to achieve the above, we have utilized PharmMapper, a web-based tool that uses a reverse pharmacophore mapping approach (spatial arrangement of features essential for a molecule to interact with a specific target receptor), along with KEGG for exploring the pathway relationship. In the validation part of the study, predicted protein targets and signalling pathways were strengthened with existing datasets of DrugBank and antibody arrays specific to vascular endothelial growth factor (VEGF) signalling in the case of 5-fluorouracil as direct experimental evidence. The current systems toxicological method illustrates the potential of the above big-data in supporting the knowledge of onco-cardiological indications which may lead to the generation of a decision making catalogue in future therapeutic prescription.